The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Methotrexate Pfizer 50mg/2ml Injection



Pfizer Healthcare IrelandPA0822/206/002

Main Information

Trade NameMethotrexate Pfizer 50mg/2ml Injection
Active SubstancesMethotrexate
Dosage FormSolution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/206/002

Group Information

ATC CodeL01BA Folic acid analogues
L01BA01 methotrexate

Status

License statusAuthorised
Licence Issued12/12/1984
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back